Trademark Overview
On Wednesday, April 19, 2023, a trademark application was filed for SUPELLIA with the United States Patent and Trademark Office. The USPTO has given the SUPELLIA trademark a serial number of 97896217. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 2, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The SUPELLIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for us...
